158 results about "Enzymatic digestion" patented technology

The invention relates to antarctic krill peptide with umami and an antarctic krill peptide mixture as well as a preparation method and application thereof. Specifically, the amino acid sequence of the euphausia superba peptide is shown as any one of SEQ ID NO: 1-5. The euphausia superba peptide mixture with delicate flavor is obtained by carrying out enzyme digestion treatment on an euphausia superba peptide solution by using incision enzyme, excision enzyme and freshness enhancing enzyme and harvesting supernate. Molecular docking simulation shows that the euphausia superba peptide disclosed by the invention can be combined with a delicate flavor receptor T1R1 / T1R3. The Antarctic krill peptide and the Antarctic krill peptide mixture can be used for development of umami seasonings, and a new idea is provided for development of marine seasonings.

The invention discloses a novel PDRN, a supramolecular liposome containing the PDRN as well as a preparation method and application of the supramolecular liposome. The preparation method of the novel PDRN comprises the following steps: (1) mixing a tissue raw material and PBS, crushing, carrying out enzymolysis, adding SDS, a Tween20 solution, polyethylene glycol octylphenol ether, a TE buffer solution and NaCl, stirring, centrifuging, mixing a supernatant with absolute ethyl alcohol, and standing to obtain a DNA crude extract; (2) carrying out breaking shearing treatment by using an ultrasonic breaking instrument; and (3) carrying out enzymolysis treatment by using restriction endonuclease and deoxyribonuclease, and the like. The PDRN supramolecular liposome is obtained by wrapping the PDRN with fatty acid extracted from marine microalgae. The fish testis are used as the raw material source, the selection range of the raw materials is widened, the preparation cost is reduced, and the organic reagent used in the preparation method is ethyl alcohol which is easy to remove and harmless.

The invention discloses application of ADAM10 or ADAM17 serving as a target spot in preparation of a medicine for preventing / treating membranous nephropathy and application of an ADAM10 or ADAM17 inhibitor in preparation of the medicine for preventing / treating membranous nephropathy. The invention finds that ADAMs mediate the deposition process of immune complexes of autoantigens such as PLA2R1 of membranous nephropathy, and enzyme digestion of podocytes to transmembrane autoantigen proteins such as PLA2R can be inhibited by performing targeted intervention on the activity of ADAMs, especially the activity of ADAM10 and ADAM17, so that immune complexes deposited in glomerulus are reduced, the podocyte damage of membranous nephropathy is improved, and the therapeutic effect is achieved.

The invention discloses a preparation method and application of yak blood peptide with anti-hypoxia and anti-fatigue functions. The method comprises the steps of raw material pretreatment, composite enzymolysis (adopting a mixture of enzyme digestion modified lumbrukinase and nattokinase), enzyme deactivation, separation and purification, ferrous chelation, Maillard reaction, concentration and drying and the like. The enzymolysis efficiency and the active peptide yield are remarkably improved through ultrasonic treatment and a composite enzymolysis technology, the stability and the anti-hypoxia capacity of peptide fragments are enhanced through ferrous chelation, and the antioxidant activity and the anti-fatigue activity are further improved through the Maillard reaction. Experiments show that the yak blood peptide prepared by the method can significantly improve the antioxidant enzyme activity, prolong the normal-pressure hypoxia survival time, prolong the swimming exhaustion time and significantly reduce the MDA content of brain tissue and myocardial tissue. The obtained product can be applied to anti-hypoxia and anti-fatigue medicines or health-care foods, and has the advantages of high process efficiency, remarkable activity, high safety and the like.

The invention provides a method for separating and culturing umbilical cord-derived mesenchymal stem cells. The method comprises the following steps: a, obtaining an umbilical cord; b, separating Wharton's jelly from the obtained umbilical cord; c, culturing the separated Wharton's jelly in a complete culture medium added with the peptide 1 and the peptide 2; d, digesting the primarily cultured mesenchymal stem cells by using an enzyme; and e, carrying out subculture on the enzyme digested mesenchymal stem cells. The mesenchymal stem cells separated from the umbilical cord are high in uniformity and high in activity.

The invention discloses a method for digesting an extracellular matrix by an immobilized enzyme and application, and relates to the technical field of biology. The method comprises the following steps: (1) performing decellularization treatment on tissues to obtain an extracellular matrix; (2) dispersing the surface functionalized microspheres in a buffer solution, adding a coupling agent, mixing, and collecting the activated microspheres; (3) dispersing the activated microspheres in a buffer solution containing pepsin, mixing, and collecting immobilized enzyme microspheres; and (4) crushing the extracellular matrix, dispersing the crushed extracellular matrix in a solution, adding the immobilized enzyme microspheres for digestion, and separating and removing the immobilized enzyme microspheres after digestion is completed. According to the method provided by the invention, the enzymolysis of the immobilized enzyme on the extracellular matrix is realized by adopting a proper microsphere particle size and a proper zeta potential. According to the method disclosed by the invention, the residual quantity of free enzyme is relatively small, so that the biological safety of the extracellular matrix material is improved.

The present invention provides a method for preparing exosomes derived from antler periosteal mesenchymal stem cells and their applications. After obtaining antler periosteal tissue, the tissue is placed in a DPBS culture dish containing antibiotics for further processing. The periosteal tissue is then minced and washed with DPBS until it is free of blood. The minced tissue is treated with digestive enzymes and incubated in a carbon dioxide (CO2) incubator to facilitate enzymatic digestion. Subsequently, alpha-MEM complete culture medium is added to further process the tissue. The digested tissue is filtered and centrifuged to isolate the primary periosteal cells, which are then counted and cultured in a suitable medium to obtain mesenchymal stem cells (MSCs) derived from antler periosteum. The cultured periosteal MSCs are further processed to isolate exosomes, which can be applied to promote the proliferation and repair of human fibroblasts, enhance skin quality, and stimulate hair growth.

The invention discloses a single bacterium transcriptome sequencing method. The method comprises the following steps: firstly, mixing microorganisms and a wrapping material, solidifying to form a jelly-shaped semi-solid, and digesting cell walls by using lysozyme to permeate bacteria; adding a reverse transcription reagent and a random primer, and capturing total RNA in bacteria to synthesize cDNA; dissolving the wrapping material, releasing single bacteria, and packaging the single bacteria and the labeled microbeads into liquid drops by using a microfluidic device; rNA in bacteria is digested through enzyme digestion, so that cDNA is released from the bacteria, the cDNA is collected and purified after demulsification, a sequencing library is constructed through amplification and addition of a sequencing joint, a cDNA product of rRNA is digested, and a cDNA product of mRNA is enriched. And performing high-throughput sequencing on the processed sample, and analyzing transcriptome information of a single microorganism. Microorganisms are wrapped by the reversible solidification porous material, centrifugal cleaning is not needed, and single-bacterium analysis can be carried out on a microorganism sample with a small initial amount.

The invention provides an analysis method for sequencing data of targeted detection microorganisms and application, by using the method provided by the invention, background interference, such as non-pathogenic or conditionally pathogenic homologous microorganisms in human host sequences, human endogenous microorganisms or samples, can be reduced; according to the method, the influence of chimeric sequence comparison generated by enzyme digestion on quality is reduced, the effective utilization rate and quality of data are improved, particularly short sequence fragments are obtained, false positive caused by probe hybridization mismatch is reduced, the sensitivity and specificity of detection are improved, and meanwhile, the operation cycle of sequencing data analysis is also shortened.

The present invention relates to an SNP chip and its preparation method and application. The SNP chip includes a solid-phase carrier modified with two kinds of primers. Through the primers, clusters of oligonucleotide probes prepared from multiple library sequences are fixed on the solid-phase carrier. The oligonucleotide probes sequentially include a P7 sequence, a linker sequence 1, a specific hybridization sequence, and a sequence of at least four nucleotides generated after enzymatic digestion of the library sequence from the 5'-end to the 3'-end. The nucleotides are arbitrarily selected from A, T, C, and G. The present invention also provides a preparation method of the SNP chip and a kit composed of the SNP chip. The SNP chip has high density, can detect more than 20 million SNP sites, has higher throughput, can meet the needs of detecting SNP variation sites with high throughput, and reduces costs through scale effect.

The invention belongs to the cross technical field of veterinary medicine and biomedicine, and relates to a construction and evaluation method of a dog spontaneous breast cancer organoid model, which specifically comprises the following steps: (1) obtaining dog spontaneous breast cancer tissues through operation or biopsy, separating tumor tissues under sterile conditions, and carrying out fine enzymolysis digestion treatment to obtain dog spontaneous breast cancer tissues; obtaining a single-cell suspension; and (2) inoculating the single-cell suspension into a three-dimensional culture system, carrying out three-dimensional culture by adopting a culture medium containing EGF, FGF and B27 in combination with a growth factor, promoting the growth and amplification of the breast cancer organs, and carrying out timely passage according to the growth condition so as to maintain the activity of the model. The model constructed by the invention completely retains genetic heterogeneity and pathological microenvironment of primary tumors, does not need gene editing, is simple and convenient to operate and low in cost, is particularly suitable for individual drug sensitivity detection of pet dogs, and provides an efficient and high-simulation experimental platform for dog breast cancer mechanism research and clinical precise medication.

This invention discloses a method for extracting high-purity PDRN from salmon testes and its application in improving skin condition, belonging to the field of bioactive ingredient extraction technology. Frozen salmon testis tissue is cleaned of blood vessels and fatty impurities, then cryogenically pulverized at -20~-25℃. The pulverized tissue is added to a pre-treatment dispersion buffer and homogenized under high pressure to obtain a DNA fragmentation solution. The precipitate is then separated by centrifugation. The precipitate is dispersed in a dedicated enzyme digestion buffer, and enzymatic digestion with protease and RNase A is performed to inactivate the enzyme. DNase I is added to the digestion solution for enzymatic cleavage. After the reaction, a stop solution is added to terminate the reaction, and the supernatant is separated by centrifugation. Ethanol is added to the supernatant for precipitation, and centrifugation yields PDRN from salmon testes. This invention, through specific buffer systems and enzymatic digestion conditions, increases the PDRN content by 40~60 kDa, allowing for better absorption and utilization by the skin, improving facial hydration and elasticity, effectively reducing facial wrinkles, and improving facial skin condition. It can be used to prepare functional cosmetics.

This invention discloses a method for inducing and culturing burdock stem cells and stem cells, belonging to the field of plant biotechnology. Using burdock roots as explants, the cambium is determined by staining, and the cambium is obtained using enzymatic digestion. The cambium is then inoculated into a specific ratio of induction solid medium and cultured in the dark to efficiently induce primary stem cells. These primary stem cells are then transferred to a proliferation solid medium for subculture and selection to obtain and maintain a vigorous, soft stem cell line. The solid stem cell line is further transferred to a liquid medium for shaking culture to establish a suspension stem cell line. This invention provides high induction efficiency, stable stem cell characteristics, and good reproducibility, offering a high-quality starting material and technical platform for in vitro preservation of burdock germplasm, large-scale production of secondary metabolites, and genetic transformation.

The invention provides a method for removing a lignocellulose hydrolysate inhibitor by using chitosan, and belongs to the technical field of biomass processing and utilization, and the method comprises the following steps: soaking crushed poplar in a dilute acid solution according to a solid-to-liquid ratio of 1: 7, adding chitosan into the solution, and carrying out a high-temperature reaction; after the reaction is finished, cooling a reaction system to room temperature, and carrying out solid-liquid separation to obtain a pretreated solid and a diluted acid pretreatment solution; rinsing the pretreated solid, washing the substrate with distilled water until the pH value is close to neutral, and rinsing for three times to obtain a pretreated material; according to the method, chitosan is added in the pretreatment process, so that dilute acid pretreatment inhibitors are reduced, and meanwhile, the problems that fermentation inhibitors challenge microbial fermentation and the enzyme digestibility of pretreated solids is limited under various pretreatment intensities in dilute acid pretreatment are solved. And the characteristics of the pretreated material are improved, the cellulose accessibility is improved, the surface structure is improved, and better conditions are provided for further utilization of biomass.

FISH PROTEIN HYDROLYSATE AND APPLICATIONS IN FARM ANIMALS The present invention relates to a protein hydrolysate originating from fish tissues or cartilages rich in protein, in particular collagen, and its applications in the feeding and welfare of farm animals, in particular pigs and poultry. In particular, the invention relates to a hydrolysate obtained by enzymatic digestion using an endopeptidase enzyme, said hydrolysate being characterized in that it has a protein fraction having a molecular profile with the following distribution: between 15 and 60% of peptides with a molecular weight of between 1000 and 5000 Da, between 20 and 40% of peptides with a molecular weight of between 500 and 1000 Da, between 10 and 40% of peptides with a molecular weight of between 150 and 500 Da, between 1 and 10% of peptides with a molecular weight of between 1000 and 50 ... molecular weight less than 150 Da. Fig. 2

The invention discloses a high-throughput extraction method and application of hair stem sample protein. The invention belongs to the field of biological detection, and particularly relates to a high-throughput extraction method and application of hair stem sample protein. The preparation method of the hair stem protein peptide fragment for mass spectrometry comprises the following steps: extracting protein from an in-vitro hair stem by adopting a pressure cycle sample preparation technology to obtain hair stem protein; and carrying out enzymolysis treatment on the hair stem protein to obtain the hair stem protein peptide fragment for mass spectrometry. The method established by the invention has simple steps, can effectively remove lipid and impurity interference on the hair stem sample, can extract the protein in the hair stem at a high recovery rate, can efficiently carry out protein enzymolysis, and realizes high-sensitivity coverage depth analysis of the hair stem proteome.

The invention discloses a construction method of a lateolabrax japonicus kiss cell line and application of the lateolabrax japonicus kiss cell line in toxicity assessment of environmental pollutant microplastics. The lateolabrax japonicus kiss cell line is constructed by the following method: under a sterile condition, taking lateolabrax japonicus kiss tissues, cutting the lateolabrax japonicus kiss tissues into pieces, and performing enzyme digestion to obtain primary cells; after the primary cells are subjected to enzyme digestion, complete medium resuspension cells are taken and inoculated into a cell culture bottle, and constant-temperature culture and passage are performed at 28 DEG C. The lateolabrax japonicus kiss cell line can preserve lateolabrax japonicus genetic resources at the cellular level, preservation is simple and convenient, an in-vitro research system is provided, a platform is built for lateolabrax japonicus cell molecular biology research, and the method is suitable for large-scale popularization and application. Meanwhile, the material can also be used as an important material and model for in-vitro researches of molecular genetics, biology, environmental toxicology and the like. According to the method, the cells of the lateolabrax japonicus kiss cell line are cultured in the culture medium containing the environmental pollutant microplastics, and the cell condition is observed, so that the toxicity of the environmental pollutant microplastics can be evaluated more accurately.

The present invention discloses a method for capturing chromatin and / or chromosome conformation and reagents used therein, and belongs to the field of three-dimensional genomics. The method comprises: subjecting target cells to in vitro cross-linking, lysis, enzymatic digestion with blunt-end restriction endonucleases to add A bases at the ends, and connecting adjacent DNA ends with BP Linker; after labeling the target protein with a specific antibody, using Tn5 fusion protein to target and enrich DNA interactions mediated by the target protein, using biotin labeling to enrich the target fragments of "DNA-tag-DNA" to obtain adjacent ligated DNA fragments, sequencing and analyzing the adjacent ligated DNA fragments, and determining the adjacent ligated DNA bound to the target protein. Compared with traditional methods, the present invention has the advantages of using conventional experimental equipment and a small number of cells, high efficiency, short cycle, low data signal-to-noise ratio, and low cost.

The present invention discloses a recombinant humanized type XVII collagen, its expression vector and genetically engineered bacteria. In the present invention, 4 functional fragments with high activity are obtained through screening. After optimizing one of the fragments and combining them in a certain order, recombinant humanized type XVII collagen JYC1703 is obtained. Or after optimizing one of the fragments, combining them in a certain order and respectively fusing GPP sequences at the amino terminus and carboxyl terminus, recombinant humanized type XVII collagens JYC1701 and JYC1702 are obtained. After codon optimization, they are amplified and cloned into an expression vector. After enzymatic digestion and linearization, they are transformed into Pichia pastoris competent cells. High-copy recombinants are screened through G418 resistance gradient to obtain Pichia pastoris genetically engineered bacteria expressing recombinant humanized type XVII collagen. The recombinant humanized type XVII collagens JYC1701, JYC1702 and JYC1703 of the present invention exhibit excellent functions of promoting cell adhesion, cell proliferation and migration, and are suitable for preparing products such as skin care or medical devices.

An alcohol-free method of extracting β-glucans such as lentinan from mushrooms is described. The method excludes the drying and pulverising of the mushrooms prior to extraction. The simultaneous use of enzymatic digestion and ultrasonication provides extracts with high levels of desired properties including 1,1-diphenyl-2-picryl hydrazyl radial scavenging activity, superoxide radical scavenging activity, iron chelating capacity, and ferric-reducing antioxidant power.

The invention belongs to a proteomics analysis technology in the technical field of biology, and particularly relates to a single-cell-level proteomics analysis system and analysis method for a mass spectrum system. The analysis system comprises a sample pretreatment optimization subsystem and a chromatography-mass spectrometry acquisition optimization subsystem, the purpose of the sample pretreatment optimization subsystem is to efficiently and stably prepare a peptide fragment mixture capable of being used on a mass spectrum machine from a trace cell sample. The sample loss is reduced by improving the protein extraction and enzymolysis efficiency of trace (nanogram-level) and single-cell-level protein samples. By optimizing mass spectrum data acquisition parameters, the identification depth and quantity of proteins are improved while the analysis time is shortened (the flux is improved). By adopting the analysis system disclosed by the invention, the accuracy and reproducibility of quantitative analysis of the micro sample proteome can be remarkably improved.

The invention discloses a method for identifying aedes albopictus and aedes aegypti based on a micro-well array and gene bar code technology, which is characterized in that a specific probe is designed aiming at a variation fragment of a 620bp target gene of a mitochondrial gene COI sequence of aedes albopictus and aedes aegypti, and the probe is a single-chain sequence rich in G basic groups; the method comprises the following steps of: preparing a probe, performing sulfydryl modification on the 5'end of the probe, preparing a hydrophilic micro-well array on a glass sheet by utilizing amination derivation, fixing by using a cross-linking agent to form a specific capture probe, hybridizing a sample and the capture probe, performing enzyme digestion, adding a silver nano-cluster aqueous solution, incubating, and developing, thereby realizing efficient, accurate and rapid detection on the aedes albopictus and aedes aegypti types. And the practical application value is very high.

The present disclosure provides methods and compositions for preparation of a nucleic acid library. In some embodiments, the nucleic acids comprise cell-free DNA, including cfDNA that is in need of analysis, such as by sequencing. The methods may comprise restriction enzyme digestion, adapter ligation, and subsequent amplification, and may provide improved approaches for reducing the number adapter dimers produced during the process. In an aspect, a method for preparing a library of nucleic acids may comprise: digesting DNA molecules with restriction enzymes to produce DNA fragments; ligating adapters to the DNA fragments by incubating with ligase to produce a mixture of adapter-ligated DNA fragments and adapter dimers; amplifying the adapter-ligated DNA fragments to produce amplified adapter-ligated DNA fragments; and reducing the quantity of the adapter dimers by differentiating between the junction between an adapter and a DNA fragment, and the junction between an adapter and another adapter.

The present invention discloses a recombinant humanized type VII collagen, its expression vector and genetically engineered bacteria. In the present invention, functional short peptides binding to cell integrin in human type VII collagen are screened, and 10 tandem repeats are designed to respectively constitute recombinant humanized type VII collagens JYC701 and JYC702. After codon optimization, they are amplified and cloned into the pPIC9K vector. After enzymatic digestion and linearization, they are transformed into Pichia pastoris cells, and high-copy recombinants are screened through G418 resistance gradient to obtain Pichia pastoris genetically engineered bacteria capable of expressing recombinant humanized type VII collagens JYC701 and JYC702. The recombinant humanized type VII collagens JYC701 and JYC702 of the present invention exhibit excellent functions of promoting cell adhesion, cell proliferation and migration, have the activity of promoting the repair of tissues such as skin and enhancing the resistance of skin, and are suitable for preparing products such as skin care products and medical devices.

This invention discloses a PEG-mediated genetic transformation method for *A. anthracnose* protoplasts. Through the preparation, transformation, and transformation of *A. anthracnose* protoplasts, and the screening of transformants, the hygromycin B resistance gene fragment was successfully transferred into the *A. anthracnose* genome, achieving successful genetic transformation of *A. anthracnose* protoplasts. More importantly, this invention establishes a new enzymatic digestion system and improves the culture mechanism in protoplast preparation. During the culture and screening of transformants, a more suitable resistance concentration is used, balancing the stringency of screening with the survival of transformants. This improves transformation efficiency, shortens the overall transformation process, and establishes a more efficient and convenient genetic transformation system for *A. anthracnose* protoplasts.

The invention discloses construction and application of two mouse esophageal squamous cell carcinoma organoid models with sex difference. The method comprises the steps of 1, tumor sample collection; step 2, carrying out single-cell enzymolysis treatment; step 3, modeling and culturing the tumor organoid; step 4, passage of the tumor organs and construction of a library for cryopreservation; compared with the prior art, the invention has the advantages that two stable and high-purity esophageal squamous carcinoma organoid strains are successfully established and are respectively named as PDO306 (from female mice) and PDO307 (from male mice). The establishment of the two new esophageal squamous cell carcinoma organoid strains makes up for the deficiency of immune microenvironment in the esophageal squamous cell carcinoma in-vitro research process, and valuable experimental materials and tools are provided for subsequent esophageal squamous cell carcinoma research.

The invention discloses a nucleotide sequence of PDRN / PN and a preparation method of PDRN / PN based on genetic engineering and microbial fermentation, and belongs to the technical field of biology. According to the method, the vibrio is adopted as a production chassis strain, and methods of pyrolysis crude extraction, enzyme digestion and magnetic bead selective separation are combined, so that the preparation of the multi-source PDRN / PN is realized, and the application range of the product is expanded. Compared with an escherichia coli system, the method has the advantages that the endotoxin pollution risk can be remarkably reduced, and the product safety is improved; compared with a yeast system, the production efficiency of PDRN / PN can be improved. Meanwhile, the method is simple and convenient to operate, is suitable for laboratory and pilot scale amplification, and has obvious industrial application potential.

The present invention relates to the field of pharmaceutical analysis technology, in particular to IPC G01N30, and more specifically to a method and application for detecting polyA tails in mRNA vaccines. The present invention provides a time-saving, labor-saving, and high-resolution method for detecting polyA tails in mRNA vaccines, comprising the following steps: S1: performing enzymatic digestion, magnetic bead purification, and elution recovery on mRNA in an mRNA vaccine solution to obtain polyA tail fragments; S2: detecting the poly A tail fragments using a liquid chromatography-mass spectrometer (LC-MS); the detection method of the present invention can detect single nucleotides and multiple oligonucleotide sequences, thereby accurately determining the polyA distribution range with high resolution; and the pretreatment method is simple, the detection time is short, the stability is greatly improved, and time is saved, and it can be used as a common characterization of mRNA vaccines.

This invention discloses a method for protein extraction and mass spectrometry pretreatment from methanogenic bacteria, belonging to the field of protein extraction technology. The method involves pretreating a methanogenic bacteria enrichment culture to remove inorganic salt ions and other impurities, resulting in a pretreated culture. Then, a lysis buffer composed of sodium dodecyl sulfate, Tris-HCl buffer, and a protease inhibitor is added to the pretreated culture, followed by ultrasonic disruption to obtain a cell lysate, from which a crude protein extract solution is obtained. Finally, the protein extract is extracted from the crude protein extract solution. This invention significantly improves protein extraction efficiency and peptide purity by optimizing the extraction process and subsequent enzymatic digestion, while preserving the methanogenic activity of the extracted protein as much as possible, providing more accurate and reliable sample support for downstream protein mass spectrometry analysis.

The present disclosure provides methods for enriching, identifying, and / or characterizing at least one host cell protein (HCP) impurity in a sample containing a viral vector. The HCP impurities can be enriched through the utilization of a library of bead-based peptide ligands. The enriched HCPs can subsequently be subjected to enzymatic digestion, generating peptides which can be identified by liquid chromatography-mass spectrometry (LC-MS) analysis to specifically identify and / or characterize said at least one HCP impurity.